Cargando…

Therapeutic Efficacy of Artemether-Lumefantrine (Coartem®) for the Treatment of Uncomplicated Falciparum Malaria in Africa: A Systematic Review

BACKGROUND: Africa still bears the largest burden of malaria as the majority of infections in the continent are caused by P. falciparum. Artemether-lumefantrine (AL, Coartem®) is the most widely used artemisinin-based combination therapy (ACT), for treating uncomplicated falciparum malaria globally....

Descripción completa

Detalles Bibliográficos
Autores principales:	Derbie, Awoke, Mekonnen, Daniel, Adugna, Meseret, Yeshitela, Biruk, Woldeamanuel, Yimtubezinash, Abebe, Tamrat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599419/ https://www.ncbi.nlm.nih.gov/pubmed/33145101 http://dx.doi.org/10.1155/2020/7371681

Ejemplares similares

Safety and efficacy of lumefantrine-artemether (Coartem(®)) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults
por: Mulenga, Modest, et al.
Publicado: (2006)

Therapeutic Efficacy of Artemether-Lumefantrine (Coartem®) in Treating Uncomplicated P. falciparum Malaria in Metehara, Eastern Ethiopia: Regulatory Clinical Study
por: Nega, Desalegn, et al.
Publicado: (2016)

Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®)
por: Tiono, Alfred B, et al.
Publicado: (2015)

The clinical efficacy of artemether/lumefantrine (Coartem(®))
por: Makanga, Michael, et al.
Publicado: (2009)

Development of a pediatric formulation for treatment of P. falciparum malaria: Coartem(®) (artemether-lumefantrine) Dispersible
por: Bassat, Quique, et al.
Publicado: (2014)

Similar efficacy and safety of artemether-lumefantrine (Coartem(®)) in African infants and children with uncomplicated falciparum malaria across different body weight ranges
por: Bassat, Quique, et al.
Publicado: (2011)

Therapeutic efficacy of Artemether/Lumefantrine (Coartem(®)) against Plasmodium falciparum in Kersa, South West Ethiopia
por: Assefa, Ashenafi, et al.
Publicado: (2010)

Artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria
por: Ehrhardt, Stephan, et al.
Publicado: (2009)

Adverse reaction to Coartem (artemether/lumefantrine) resulting in oculogyric crisis
por: Amponsah, Emmanuel Kofi, et al.
Publicado: (2021)

Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India
por: Valecha, Neena, et al.
Publicado: (2009)

Efficacy of artemether–lumefantrine therapy for the treatment of uncomplicated Plasmodium falciparum malaria in Southwestern Ethiopia
por: Mekonnen, Seleshi Kebede, et al.
Publicado: (2015)

Azithromycin resistant gonococci: a literature review
por: Derbie, Awoke, et al.
Publicado: (2020)

Cryptococcal antigenemia and its predictors among HIV infected patients in resource limited settings: a systematic review
por: Derbie, Awoke, et al.
Publicado: (2020)

Efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Nepal
por: Ghimire, Prakash, et al.
Publicado: (2018)

Assessment of therapeutic efficacy and safety of artemether-lumefantrine (Coartem®) in the treatment of uncomplicated Plasmodium falciparum malaria patients in Bahir Dar district, Northwest Ethiopia: an observational cohort study
por: Ebstie, Yehenew A., et al.
Publicado: (2015)

Exposure to artemether-lumefantrine (Coartem®) in first trimester pregnancy in an observational study in Zambia
por: Manyando, Christine, et al.
Publicado: (2015)

Possible Clinical Failure of Artemether-Lumefantrine in an Italian Traveler with Uncomplicated Falciparum Malaria.
por: Repetto, Ernestina C., et al.
Publicado: (2011)

Therapeutic efficacy of artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Benin
por: Ogouyèmi-Hounto, Aurore, et al.
Publicado: (2016)

Therapeutic efficacy of artemether–lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Enfranze, north-west Ethiopia
por: Getnet, Gebeyaw, et al.
Publicado: (2015)

HPV E6/E7 mRNA test for the detection of high grade cervical intraepithelial neoplasia (CIN2+): a systematic review
por: Derbie, Awoke, et al.
Publicado: (2020)

In vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in Central Ethiopia
por: Hwang, Jimee, et al.
Publicado: (2011)

Therapeutic Efficacy of Artemether-Lumefantrine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in Northern Ethiopia
por: Kinfu, Gebremedhin, et al.
Publicado: (2012)

Clinical Efficacy of Artemether-Lumefantrine in Congolese Children with Acute Uncomplicated Falciparum Malaria in Brazzaville
por: Ndounga, Mathieu, et al.
Publicado: (2012)

Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 2018
por: Dentinger, Catherine M., et al.
Publicado: (2021)

Open-label trial on efficacy of artemether/lumefantrine against the uncomplicated Plasmodium falciparum malaria in Metema district, Northwestern Ethiopia
por: Wudneh, Feven, et al.
Publicado: (2016)

Human papillomavirus genotype distribution in Ethiopia: an updated systematic review
por: Derbie, Awoke, et al.
Publicado: (2022)

Correction to: Human papillomavirus genotype distribution in Ethiopia: an updated systematic review
por: Derbie, Awoke, et al.
Publicado: (2022)

Acceptance of human papillomavirus vaccination and parents’ willingness to vaccinate their adolescents in Ethiopia: a systematic review and meta-analysis
por: Derbie, Awoke, et al.
Publicado: (2023)

Therapeutic efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in North-Eastern Tanzania
por: Shayo, Alex, et al.
Publicado: (2014)

In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014
por: Paczkowski, Magdalena, et al.
Publicado: (2016)

High therapeutic efficacy of artemether–lumefantrine and dihydroartemisinin–piperaquine for the treatment of uncomplicated falciparum malaria in Somalia
por: Warsame, Marian, et al.
Publicado: (2019)

Therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Chewaka District, Ethiopia
por: Abamecha, Abdulhakim, et al.
Publicado: (2020)

Quinine plus clindamycin vs artemether-lumefantrine for treatment of uncomplicated falciparum malaria in western Kenya
por: Obonyo, Charles O., et al.
Publicado: (2022)

The Use of Artemether-Lumefantrine for the Treatment of Uncomplicated Plasmodium vivax Malaria
por: Bassat, Quique
Publicado: (2011)

Low level of knowledge about cervical cancer among Ethiopian women: a systematic review and meta-analysis
por: Derbie, Awoke, et al.
Publicado: (2021)

Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
por: Peto, Thomas J, et al.
Publicado: (2022)

Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in four malaria endemic states of India
por: Krishna, Sri, et al.
Publicado: (2021)

Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
por: Assefa, Ashenafi, et al.
Publicado: (2022)

Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial
por: Achan, Jane, et al.
Publicado: (2009)

Efficacy and Safety of Artemether-Lumefantrine in the Treatment of Acute, Uncomplicated Plasmodium falciparum Malaria: A Pooled Analysis
por: Makanga, Michael, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_6oadk0l8bea8irmuvpshivbmji